- Clinical Interests
- Multiple sclerosis
- Neuromyelitis optica
- Transverse myelitis
- Optic neuritis
- health care in humanitarian emergencies
- Medical Education
- PhD, Johns Hopkins Bloomberg School of Public Health
- MD, University of Saskatchewan College of Medicine
- Residency, Mayo Clinic
- Fellowship, The Johns Hopkins Hospital
- Board Certifications
- Boston: Massachusetts General Hospital
- Insurances Accepted
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Provider Gender
Farrah J. Mateen, MD, PhD is an Associate Professor of Neurology at Harvard Medical School.
She is originally from Saskatchewan, Canada where she received her medical degree (2005). She pursued adult neurology training at the Mayo Clinic in Minnesota (American Board of Psychiatry and Neurology, 2009) and a Fellowship in Medical Ethics at Harvard University (2008). Dr. Mateen's clinical and research fellowship training in neuroimmunology and neurological infections was at the Johns Hopkins Hospital (2012), supported by the American Brain Foundation. Dr. Mateen completed her doctoral studies in International Health at the Johns Hopkins University (2014) as a Sommer Scholar.
Dr. Mateen's clinical practice is dedicated to multiple sclerosis and neuromyelitis optica where she enjoys seeing patients with diagnostically and therapeutically complex conditions. She leads a clinical trial funded by the National MS Society on light therapy for MS-related fatigue. She also performs research on other aspects of MS, ADEM (acute disseminated encephalomyelitis), and related disorders.
Dr. Mateen is principal investigator of the Bhutan Epilepsy Project, a multi-country study of a smartphone-based electroencephalogram (EEG), through the support of the Charles Hood Foundation, the National Institutes of Health, and others. Her work includes collaborations throughout Africa and Asia.
Dr. Mateen is the past chair of the American Neurological Association International Outreach Committee and of the American Academy of Neurology's Global Health Section (2014-2016) and Ethics Section (2011-2013). She has worked with the UN High Commissioner for Refugees, World Health Organization, Polio Eradication Initiative, and several NGOs. Dr. Mateen has traveled to >35 countries and published >120 academic manuscripts to advance neurological disease research and clinical care.
- Research Summary
Dr. Mateen performs research dedicated to the understanding of: (1) Multiple sclerosis and related demyelinating diseases to study new treatments and biomarkers for patients ; and (2) Neurological diseases from a global health perspective with a focus on resource-limited settings in Africa and Asia.
Dr. Mateen's longterm research goal is to advance neurological care through low-cost, evidence-based interventions, informed by detailed clinical research.
Dr. Mateen has published >120 articles, including research maunscripts, reviews, and editorials.
In recognition of National Multiple Sclerosis Awareness month, Farrah Mateen, MD, PhD, of the Multiple Sclerosis Clinic at Massachusetts General Hospital, discusses treatment options for MS patients and how research could help in diagnosing and monitoring the disease.
15 Parkman Street
Boston, MA 02114-3117